Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Overview of attention for article published in Journal of Thrombosis & Haemostasis, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 10 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 81 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

Clinical guideline published by United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) on 16 Jun 2016

The United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) is a professional body for medical practitioners involved in the care of individuals with haemophilia and bleeding disorders across the UK. It manages the National Haemophilia Database and provides clinical guidelines and resources for healthcare professionals.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.